GeneDx Holdings (WGS) Other Operating Expenses (2021 - 2024)

GeneDx Holdings (WGS) has 4 years of Other Operating Expenses data on file, last reported at $2.6 million in Q4 2024.

• Other Operating Expenses for Q4 2024 came in at $2.6 million, down 20.59% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.6 million (up 285.59% YoY), and the FY2023 annual result was -$2.0 million, up 69.0% from the prior year.
• Other Operating Expenses rose to $2.6 million in Q4 2024 per WGS's latest filing, from -$774000.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $13.0 million in Q2 2021 and troughed at -$2.8 million in Q3 2023.
• A 4-year average of $705080.0 and a median of -$874000.0 in 2024 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 306.38% in 2023 and fell as far as 64.64% in 2023.
• A 4-year view of Other Operating Expenses shows it stood at $13.0 million in 2021, then sank by 112.3% to -$1.6 million in 2022, then soared by 306.38% to $3.3 million in 2023, then dropped by 20.59% to $2.6 million in 2024.
• Business Quant data shows WGS's Other Operating Expenses at $2.6 million in Q4 2024, -$774000.0 in Q3 2024, and -$874000.0 in Q2 2024.